Publikationen

Prof. Dr. med. Martin Wagenmann

Originalarbeiten

  1. Jankowski R, Wagenmann M, Baroody FM, Naclerio R. Effect of terfenadine on nasal provocation. Int Arch Allergy Imm. 1993;101(3):311–317.
  2. Baroody FM, Wagenmann M, Naclerio RM. Comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol. 1993;74(6):2661–2671.
  3. Wagenmann M, Baroody FM, Jankowski R, Nadal J, Roecker-Cooper M, Wood CC, Naclerio RM. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy. 1994;24(3):288–290.
  4. Wagenmann M, Baroody FM, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994;93(3):594–605.
  5. Röseler S, Holtappels G, Wagenmann M, Bachert C. Elevated levels of interleukins IL-1 beta, IL-6 and IL-8 in naturally acquired viral rhinitis. Eur Arch Otorhinolaryngol. 1995;252 Suppl 1:S61–3.
  6. Bachert C, Wagenmann M, Hauser U. Proinflammatory cytokines: measurement in nasal secretion and induction of adhesion receptor expression. Int Arch Allergy Imm. 1995;107(1-3):106–108.
  7. Wagenmann M, Baroody FM, Desrosiers M, Hubbard WC, Ford S, Lichtenstein LM, Naclerio RM. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. Clin Exp Allergy. 1996;26(4):371–378.
  8. Bachert C, Wagenmann M, Vossen-Holzenkamp S. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge. Rhinology. 1996;34(3):140–143.
  9. Hauser U, Wagenmann M, Rudack C, Cromwell O, Ganzer U. Specific immunotherapy suppresses IL-1β and IL-8 levels in nasal secretions: A possible explanation for the inhibition of inflammatory cell migration. Oto-Rhino-Laryngologia Nova. 1997;(1):31–39.
  10. Wagenmann M, Rudack C, Bachert C. Suppression der IL-8 Sekretion in das Nasensekret durch die spezifische Immuntherapie: Mögliche Ursache der gehemmten Migration eosinophiler Granulozyten? Allergologie. 1997;(4):184–191.
  11. Rudack C, Hillebrandt M, Wagenmann M, Hauser U. [Treatment of tinnitus with lidocaine? A report of clinical experiences]. HNO. 1997;45(2):69–73.
  12. Wagenmann M, Baroody FM, Cheng CC, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997;155(2):426–431.
  13. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol. 1997;99(6 Pt 1):837–842.
  14. Rudack C, Hauser U, Wagenmann M, Bachert C, Ganzer U. [Cytokine pattern in various forms of sinusitis]. Laryngo-Rhino-Otol. 1998;77(1):34–37.
  15. Hauser U, Horlitz S, Willich K, Wagenmann M. [The snap system. Advantages of a new attachment system for osseointegrated ear epitheses]. HNO. 1999;47(5):502–507.
  16. Hoffmann TK, Balló H, Braunstein S, Van Lierop A, Wagenmann M, Bier H. Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck. Oral Oncol. 2001;37(1):50–56.
  17. Bachert C, van Kempen MJ, Höpken K, Holtappels G, Wagenmann M. Elevated levels of myeloperoxidase, pro-inflammatory cytokines and chemokines in naturally acquired upper respiratory tract infections. Eur Arch Otorhinolaryngol. 2001;258(8):406–412.
  18. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter W, Tasman AJ, Wagenmann M. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Allergo J. 2002;(11):29–36.
  19. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW, Tasman AJ, Wagenmann M. [Application of the nasal provocation test on diseases of the upper airways.]. Laryngo-Rhino-Otol. 2003;82(3):183–188.
  20. Wagenmann M, Schubert K, Helmig P, Gärtner-Akerboom M, Chaker A, Scheckenbach K. Der ELISPOT-Assay, eine hochsensitive Methode zur Untersuchung der Zytokinproduktion der Nasenschleimhaut. Allergologie. 2005;28(10):401–411.
  21. Kleine-Tebbe J, Kunkel G, Wagenmann M. Diagnostische Fallstricke bei ausgeprägter Pollenallergie. Allergo J. 2005. 12:215–219.
  22. Wagenmann M, Schumacher L, Bachert C. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge. Allergy. 2005;60(9):1132–1138.
  23. Marini A, Wagenmann M, Ting E, Hengge UR. Squamous cell cancer and human papillomavirus infection in oral lichen planus: case report and literature review. Dermatol Surg. 2007;33(6):756–760.
  24. Stuck BA, Bachert C, Federspil P, Hosemann W, Klimek L, Mosges R, Pfaar O, Rudack C, Sitter H, Wagenmann M, Hörmann K. [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery]. HNO. 2007;55(10):758–60, 762–4, 766–77.
  25. Scheckenbach K, Balz V, Wagenmann M, Hoffmann TK. An intronic alteration of the fibroblast growth factor 10 gene causing ALSG-(aplasia of lacrimal and salivary glands) syndrome. BMC Med Genet. 2008;9:114.
  26. Scheckenbach K, Winterhalter S, Chaker A, Hoffmann TK, Ramp U, Wagenmann M. [MALT lymphoma of the orbit]. HNO. 2008;56(2):161–164.
  27. Scheckenbach K, Bier H, Hoffmann TK, Windfuhr JP, Bas M, Laws H, Plettenberg C, Wagenmann M. [Risk of hemorrhage after adenoidectomy and tonsillectomy. Value of the preoperative determination of partial thromboplastin time, prothrombin time and platelet count]. HNO. 2008;56(3):312–320.
  28. Schipper J, Hoffmann T, Wagenmann M, Stummer W, Knapp F, Klenzner T, Turowski B. [Significance of emissary veins in surgical treatment of temporal paragangliomas]. HNO. 2009;57(2):146–152.
  29. Kleine-Tebbe J, Bufe A, Ebner C, Eigenmann PA, Friedrichs F, Fuchs T, Huttegger I, Jung K, Klimek L, Kopp MV, Lässig W, Merk H, Niggemann B, Rabe U, Saloga J, Schmid-Grendelmeier P, Sitter H, Virchow JC, Wagenmann M, Wedi B, Worm M. Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für Allergologie und Immunologie (SGAI). Allergo J. 2009;18:508–537.
  30. Schuler PJ, Cohnen M, Greve J, Plettenberg C, Chereath J, Bas M, Koll C, Scheckenbach K, Wagenmann M, Schipper J, Hoffmann TK. Surgical management of retropharyngeal abscesses. Acta Otolaryngol. 2009;129(11):1274–1279.
  31. Scheckenbach K, Papadopoulou G, Hoffmann TK, Chaker A, Bier H, Schipper J, Balz V, and Wagenmann M. The checkpointkinase 2 (CHK2) 1100delC germ line mutation is not associated with the development of squamous cell carcinoma of the head and neck (SCCHN). J Negat Results Biomed. 2010;9:10.
  32. Scheckenbach K, Cornely O, Hoffmann TK, Engers R, Bier H, Chaker A, Greve J, Schipper J, and Wagenmann M. Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis. Auris Nasus Larynx. 2010 Jun.;37(3):322–328.
  33. Kleine-Tebbe J, Bufe A, Ebner C, Eigenmann PA, Friedrichs F, Fuchs T, Huttegger I, Jung K, Klimek L, Kopp MV, Lässig W, Merk H, Niggemann B, Rabe U, Saloga J, Schmid-Grendelmeier P, Sitter H, Virchow JC, Wagenmann M, Wedi B, Worm M. Specific Immunotherapy (hyposensitization) for IgE-mediated allergic diseases. Allergologie. 2010;33(1):3–34.
  34. Schäfer T, Schnoor M, Wagenmann M, Klimek L, Bachert C. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. Rhinology. 2011.;49(3):272–280.
  35. Dumitru AF, Shamji M, Wagenmann M, Hindersin S, Scheckenbach K, Greve J, Klenzner T, Hess L, Nebel S, Zimmermann C, Zahner C, Schmidt-Weber CB, and Chaker AM. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine. J Allergy Clin Immunol. 2011;127(6):1515–1521.e6.
  36. Stuck BA, Bachert C, Federspil P, Hosemann W, Klimek L, Mösges R, Pfaar O, Rudack C, Sitter H, Wagenmann M, Weber R, Hörmann K.: [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery]. HNO 2012;60:141–162.
  37. Baumann R, Rabaszowski M, Stenin I, Gaertner-Akerboom M, Scheckenbach K, Wiltfang J, Schipper J, Wagenmann M: The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms. Clin Transl Allergy 2012;2:13.
  38. Scheckenbach K, Wagenmann M, Freund M, Schipper J, Hanenberg H: Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines. Klin Padiatr 2012;224:132–138.
  39. Hoffmann TK, Hindy El N, Müller OM, Schuler PJ, Bergmann C, Hierner R, Lehnerdt G, Mattheis S, Wagenmann M, Schipper J, Sure U, Lang S, Hänggi D, Sandalcioglu IE: Vascularised local and free flaps in anterior skull base reconstruction. Eur Arch Otorhinolaryngol 2013, 270:899–907.
  40. Baumann R, Rabaszowski M, Stenin I, Tilgner L, Scheckenbach K, Wiltfang J, Schipper J, Chaker A, Wagenmann M: Comparison of the nasal release of IL-4, IL-10, IL-17, CCL13/MCP-4, and CCL26/eotaxin-3 in allergic rhinitis during season and after allergen challenge. Am J Rhinol Allergy. 2013;27(4):266–72.
  41. Baumann R, Rabaszowski M, Stenin I, Tilgner L, Gaertner-Akerboom M, Scheckenbach K, Wiltfang J, Chaker A, Schipper J, Wagenmann M: Nasal levels of soluble IL-33R ST2 and IL-16 in allergic rhinitis: inverse correlation trends with disease severity. Clin Exp Allergy. 2013;43(10):1134–43.
  42. Schipper J, Hoffmann TK, Klenzner T, Wagenmann M. Unsuccessful duraplasty technique or persisting/recanalized Sternberg's canal? [Frustrane Duraplastiktechnik oder persistierender/rekanalisierter Sternberg Kanal der Keilbeinhöhle?]. Laryngo-Rhino-Otol. 2013;92(6):400–5.
  43. Scheckenbach K, Baldus SE, Balz V, Freund M, Pakropa P, Sproll C, et al. RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC). Oral Oncol. 2014 Mar;50(3):196–9. 

Übersichtsarbeiten

  1. Wagenmann M, Naclerio RM. Anatomic and physiologic considerations in sinusitis. J Allergy Clin Immunol. 1992;90(3 Pt 2):419–423.
  2. Wagenmann M, Naclerio RM. Complications of sinusitis. J Allergy Clin Immunol. 1992;90(3 Pt 2):552–554.
  3. Bachert C, Wagenmann M. Aspirinintoleranz. HNO. 1993;41(12):16–17.
  4. Bachert C, Wagenmann M, Holtappels G. Cytokines and adhesion molecules in allergic rhinitis. Am J Rhinol. 1998;12(1):3–8.
  5. Bachert C, Wagenmann M, Rudack C, Höpken K, Hillebrandt M, Wang D, van Cauwenberge P. The role of cytokines in infectious sinusitis and nasal polyposis. Allergy. 1998;53(1):2–13.
  6. Hoffmann TK, Wagenmann M, Kojda G, Bender HG, Friebe-Hoffmann U. [Symptoms and therapy for pregnancy rhinitis]. Z Geburtshilfe Neonatol. 2004;208(4):126–132.
  7. Hoffmann TK, Wagenmann M. Klinik und Therapie der Alternase. Apothekenmagazin. 2005;23(10):242–249.
  8. Wagenmann M, Schipper J. Die transnasale Route zur Schädelbasis. Von der Nasennebenhöhlenchirurgie zur Schädelbasischirurgie. Laryngo-Rhino-Otol. 2011;90(S 01):S1–S15.
  9. Raap U, Wagenmann M, Pfaar O. [Allergen-specific immunotherapy in pet allergy - an update]. Hautarzt. 2011;62(9):657–662
  10. Chaker A, Wagenmann M. Schleimhaut der Nase. Allergo Journal. 2013;22(8):2
  11. Klimek L, Bachert C, Wagenmann M, Ring J, Pfaar O. MP29-02 (Dymista®) – a new treatment option for allergic rhinitis. [MP29-02 (Dymista®) – Eine neue Behandlungsoption für die allergische Rhinitis] Allergologie. 2014;37(2):55–68.
  12. Schröder K, Finis D, Meller S, Buhren BA, Wagenmann M, Geerling G. Die saisonale und perenniale allergische Rhinokonjunktivitis. [Seasonal and perennial allergic rhinoconjunctivitis]. Klin Monatsbl Augenheilkd. 2014;231(5):496–504.

Buchbeiträge

  1. Bachert C, Hauser U, Brandt A, Wagenmann M, Holtappels G. Eosinophile und Interleukin-5: Angelpunkt bei der Polyposis nasi. In: Mosges R, Schlöndorff G, editors. Die Folgen der Allergie - Rhinitis, Asthma, Polyposis nasi. Zülpich: Biermann; 1996. p. 44–51.
  2. Wagenmann M, Bachert C. Allergische Rhinosinusitis. In: Heppt W, Bachert C, editors. Praktische Allergologie. Schwerpunkt HNO-Heilkunde. Stuttgart, New York: Georg Thieme Verlag; 1998. p. 15–20.
  3. Wagenmann M. Die allergische Pilzsinusitis. In: Schultze-Werninghaus G, Fuchs T, Bachert C, Wahn U, editors. Manuale allergologicum. Oberhaching: Dustri Verlag; 2004. p. 825–840. 
  4. Togias A, Corren J, Wagenmann M. Nasal Provocation Testing. In: Adkinson NF, Bochner B, Busse WW, Holgate ST, Lemanske RF, Simons FER, editors. Middleton's Allergy: Principles and Practice. Mosby, Elsevier; 2009. p. 1281–1294.
  5. Scheckenbach K, Wagenmann M. Umweltmedizin. In: Reiß M, editor. Facharztwissen HNO-Heilkunde. Heidelberg: Springer; 2009. p. 107–108. 
  6. Wagenmann M, Scheckenbach K. Immunologische Grundlagen allergischer Erkrankungen. In: Heppt W, Bachert C, editors. Praktische Allergologie. Stuttgart, New York: Georg Thieme Verlag; 2011. p. 13–24.


© Martin Wagenmann 2017